1. Home
  2. BDTX vs KOPN Comparison

BDTX vs KOPN Comparison

Compare BDTX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • KOPN
  • Stock Information
  • Founded
  • BDTX 2014
  • KOPN 1984
  • Country
  • BDTX United States
  • KOPN United States
  • Employees
  • BDTX N/A
  • KOPN N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • KOPN Semiconductors
  • Sector
  • BDTX Health Care
  • KOPN Technology
  • Exchange
  • BDTX Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • BDTX 132.5M
  • KOPN 138.4M
  • IPO Year
  • BDTX 2020
  • KOPN 1992
  • Fundamental
  • Price
  • BDTX $2.41
  • KOPN $1.56
  • Analyst Decision
  • BDTX Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • BDTX 5
  • KOPN 3
  • Target Price
  • BDTX $15.60
  • KOPN $2.58
  • AVG Volume (30 Days)
  • BDTX 1.4M
  • KOPN 3.1M
  • Earning Date
  • BDTX 08-05-2025
  • KOPN 08-07-2025
  • Dividend Yield
  • BDTX N/A
  • KOPN N/A
  • EPS Growth
  • BDTX N/A
  • KOPN N/A
  • EPS
  • BDTX 0.09
  • KOPN N/A
  • Revenue
  • BDTX $70,000,000.00
  • KOPN $50,841,018.00
  • Revenue This Year
  • BDTX N/A
  • KOPN $8.02
  • Revenue Next Year
  • BDTX N/A
  • KOPN $20.99
  • P/E Ratio
  • BDTX $27.30
  • KOPN N/A
  • Revenue Growth
  • BDTX N/A
  • KOPN 28.16
  • 52 Week Low
  • BDTX $1.20
  • KOPN $0.56
  • 52 Week High
  • BDTX $6.75
  • KOPN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 57.88
  • KOPN 56.76
  • Support Level
  • BDTX $2.15
  • KOPN $1.55
  • Resistance Level
  • BDTX $2.71
  • KOPN $1.70
  • Average True Range (ATR)
  • BDTX 0.17
  • KOPN 0.09
  • MACD
  • BDTX -0.01
  • KOPN -0.01
  • Stochastic Oscillator
  • BDTX 55.36
  • KOPN 43.75

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: